Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device Firms Seek More Exemptions, Pricing Flexibility For Oncoming Excise Tax

This article was originally published in The Pink Sheet Daily

Executive Summary

Written comments were due May 7 on the Internal Revenue Service’s proposed regulation to implement a 2.3% excise tax on device sales in the lead-up to a May 16 public hearing.

You may also be interested in...



Device Tax Repeal As Tax Reform: AdvaMed Makes The Case

AdvaMed aims to “decouple” discussion of the device tax from the health care reform debate and link its repeal to broader efforts focused on improving the U.S. tax system.

Tax Time Cometh: IRS Issues Device Tax Proposed Rule

IRS issued the draft regulation in the lead up to the Jan. 1, 2013, launch date of the 2.3% federal excise tax on most U.S. device sales, enacted in 2010 under the Affordable Care Act. The agency is collecting comments on the proposal through May and will hold a public meeting May 16.

Emerging Markets Bring Risks That Require More Supply Chain Visibility – Report

Industry survey outlines challenges of globalization cited by medtech execs, including potential for insufficient supply chain visibility. Report suggests IT improvements and “on-demand visibility” solutions could help iron out the kinks.

Topics

UsernamePublicRestriction

Register

LL1133546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel